Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · IEX Real-Time Price · USD
6.28
+0.33 (5.55%)
Feb 6, 2023, 10:56 AM EST - Market open
Total Valuation
GNTA has a market cap or net worth of $114.40 million. The enterprise value is $77.91 million.
| Market Cap | 114.40M |
| Enterprise Value | 77.91M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
GNTA has 18.22 million shares outstanding.
| Shares Outstanding | 18.22M |
| Owned by Insiders (%) | 57.55% |
| Owned by Institutions (%) | 2.14% |
| Float | 11.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 62.44 |
| PB Ratio | 2.94 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 31.15
| Current Ratio | 31.15 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -14.80% and return on invested capital (ROIC) is -206.20%.
| Return on Equity (ROE) | -14.80% |
| Return on Assets (ROA) | -13.90% |
| Return on Capital (ROIC) | -206.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$945,724 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.59% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -25.59% |
| 50-Day Moving Average | 5.67 |
| 200-Day Moving Average | 5.87 |
| Average Volume (30 Days) | 4,640 |
Short Selling Information
| Short Interest | 1,835 |
| Short Previous Month | 2,561 |
| Short % of Shares Out | 0.01% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.25 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.11M |
| Pretax Income | -3.78M |
| Net Income | -3.78M |
| EBITDA | -3.76M |
| EBIT | -3.77M |
| Earnings Per Share (EPS) | -$0.23 |
Balance Sheet
| Cash & Cash Equivalents | 36.50M |
| Total Debt | n/a |
| Net Cash | 36.50M |
| Net Cash Per Share | $2.00 |
| Equity / Book Value | 38.94M |
| Book Value Per Share | 2.14 |
| Working Capital | 38.11M |
Cash Flow
In the last 12 months, operating cash flow was -$5.09 million and capital expenditures -$8,521, giving a free cash flow of -$5.10 million.
| Operating Cash Flow | -5.09M |
| Capital Expenditures | -8,521 |
| Free Cash Flow | -5.10M |
| FCF Per Share | -$0.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GNTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -3.31% |
| FCF Yield | -4.45% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
Analyst Forecast
The average price target for GNTA is $21.17, which is 237.10% higher than the current price. The consensus rating is "Buy".
| Price Target | $21.17 |
| Price Target Difference | 237.10% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |